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Abstract
Flavin electron transferases can catalyze one- or two-electron reduction of quinones including bioreductive antitumor
quinones. The recombinant neuronal nitric oxide synthase (nNOS) reductase domain, which contains the FAD-FMN
prosthetic group pair and calmodulin-binding site, catalyzed aerobic NADPH-oxidation in the presence of the model
quinone compound menadione (MD), including antitumor mitomycin C (Mit C) and adriamycin (Adr). Calcium/calmodulin
(Ca2/CaM) stimulated the NADPH oxidation of these quinones. The MD-mediated NADPH oxidation was inhibited in the
presence of NAD(P)H:quinone oxidoreductase (QR), but Mit C- and Adr-mediated NADPH oxidations were not. In
anaerobic conditions, cytochrome b5 as a scavenger for the menasemiquinone radical (MD3) was stoichiometrically
reduced by the nNOS reductase domain in the presence of MD, but not of QR. These results indicate that the nNOS
reductase domain can catalyze a only one-electron reduction of bivalent quinones. In the presence or absence of Ca2/CaM,
the semiquinone radical species were major intermediates observed during the oxidation of the reduced enzyme by MD, but
the fully reduced flavin species did not significantly accumulate under these conditions. Air-stable semiquinone did not react
rapidly with MD, but the fully reduced species of both flavins, FAD and FMN, could donate one electron to MD. The
intramolecular electron transfer between the two flavins is the rate-limiting step in the catalytic cycle [H. Matsuda, T.
Iyanagi, Biochim. Biophys. Acta 1473 (1999) 345^355). These data suggest that the enzyme functions between the 1e333e3
level during one-electron reduction of MD, and that the rates of quinone reductions are stimulated by a rapid electron
exchange between the two flavins in the presence of Ca2/CaM. ß 2000 Elsevier Science B.V. All rights reserved.
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1. Introduction
Quinones (Qs) including antitumor Qs undergo
facile reduction and oxidation. A one-electron reduc-
tion of a Q gives the semiquinone radicals while a
two-electron reduction gives hydroquinone. In 1969
and 1970, Iyanagi and Yamazaki [1,2] reported that
the reduction of Qs and oxygen by £avin enzymes
falls into three mechanistic categories: one-electron,
two-electron and mixed-type reactions. NADPH-cy-
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Abbreviations: NOS, nitric oxide synthase; nNOS, neuronal
NOS; P450 reductase, NADPH-cytochrome P450 reductase;
QR, NAD(P)H:quinone oxidoreductase; CaM, Ca2-dependent
calmodulin; MD, menadione (2-methyl-,1,4-naphthoquinone);
MD3, anionic semiquinone of MD; Adr, adriamycin; Mit C,
mitomycin C; FAD and FMN are the oxidized forms, FADHb
and FMNHb are the one electron(semiquinone)-reduced forms,
and FADH2 and FMNH2 are the fully reduced forms of the
two £avins; EPR, electron paramagnetic resonance
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tochrome P450 reductase (P450 reductase) catalyzes
the one-electron reduction of Qs, including antitu-
mor Qs. On the other hand, NAD(P)H: Q oxidore-
ductase (QR) catalyzes the obligatory two-electron
reduction of Q to hydroquinone [2^5].
Neuronal nitric oxide synthase (nNOS) consists of
a C-terminal reductase domain and a N-terminal
oxygenase domain. The C-terminal reductase domain
contains binding sites for Ca2-dependent calmodu-
lin (CaM), FAD, FMN, and NADPH [6,7] and has
redox properties similar to those of P450 reductase
[8^12]. This domain can mediate transfer of electrons
from NADPH to the cytochrome P450-like heme
domain [13^15]. This process is facilitated by the
binding of calcium/calmodulin (Ca2/CaM) to the
CaM-binding site located near the center of the en-
zyme [6,7]. The electron transfer from the reductase
domain to the heme domain is thought to be stimu-
lated by Ca2/CaM [13,16]. The isoenzymes of NOS
can catalyze the reduction of several exogenous elec-
tron acceptors, such as cytochrome c, ferricyanide,
and molecular oxygen [17^19]. The endothelial
NOS (eNOS) [20] and its reductase domain [21] can
catalyze the one-electron reduction of adriamycin
(Adr). nNOS can also catalyze the one-electron re-
duction of adrenochrome [22] and naphthoquinones
[21,23]. These reactions are thought to occur at the
reductase domain of the enzyme. However, the role
of a FAD-FMN pair in the three NOS isoenzymes in
the reaction with exogenous electron acceptors in-
cluding Q and ferricyanide is not fully understood.
P450 reductase, which contains FAD and FMN in
equimolar amounts [8,9], can catalyze a typical one-
electron reduction of bivalent exogenous Qs [1^
5,23,24]. The one-electron reduction potential of Qs
is related to their reduction rates by P450 reductase
[25^27]. If the one-electron redox potential of a Q
(Q/Q3) is below 3155 mV, which is the one-electron
redox potential for O2/O32 at pH 7.0 on the molar
basis, the semiquinone radical can transfer the elec-
tron to molecular oxygen (O2) resulting in the for-
mation of superoxide anion radical (O32 ) [1^
4,20,24,28]. Each £avin of the reductase has an indi-
vidual function, that is, FAD accepts two reducing
equivalents from NADPH (dehydrogenase £avin)
and FMN acts as a one-electron carrier (£avodox-
in-type £avin) [8^10]. The fully reduced FMN is the
most reactive species in the one-electron reduction of
Qs, and a 1e333e3 catalytic cycle has been pro-
posed [9,29].
In the present study, we examined whether the
recombinant nNOS reductase domain, which con-
tains an FAD/FMN prosthetic group pair and a
CaM-binding site (amino acid residues 718^1429)
could catalyze the one-electron reduction of mena-
dione (2-methyl-,1,4-naphthoquinone) (MD), mito-
mycin C (Mit C) and adriamycin (Adr) by a mecha-
nism similar to that of the P450 reductase, and if
these activities are stimulated by Ca2/CaM. Fur-
thermore, the role of an FAD-FMN pair of the
nNOS reductase domain is discussed in the context
with that of the P450 reductase.
2. Materials and methods
2.1. Materials
The synthetic CaM peptide, amino acid residues
726^746, RRAIGFKKLAEAVKFSAKLM, was
kindly supplied by Dr. Hisaaki Taniguchi (Fujita
Health University, Japan). The rat NADPH-cyto-
chrome P450 reductase cDNA [30] was kindly sup-
plied by Dr. Yoshiyasu Yabusaki (Biotechnology
Laboratory, Sumitomo). MD, Mit C, and Adr were
purchased from Sigma. Pig brain calmodulin and
cytochrome c were obtained from Boehringer Mann-
heim. NADPH and NADH were obtained from Ori-
ental Yeast. Catalase and glucose oxidase were ob-
tained from Sigma. All other materials were of
analytical reagent grade.
2.2. Enzymes
The rat nNOS reductase domain (amino acid res-
idues 718^1429) was expressed in Escherichia coli,
strain BL21, and was puri¢ed as described previously
[31]. QR was prepared from rat livers [32,33]. Tryp-
sin-solubilized cytochrome b5 [34] was prepared from
pig liver microsomes. The rat P450 reductase (amino
acid residues 57^676) was constructed in the expres-
sion vector pCWori and expressed in E. coli, strain
BL21. The resulting recombinant enzyme was puri-
¢ed as described previously [8,29].
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2.3. Methods
Optical spectra were measured with a Shimazu
Model MPS UV-2000 spectrophotometer in a sample
compartment at 25‡C. Stopped-£ow experiments
were performed using a Union Giken Model
RA401 stopped-£ow spectrophotometer, equipped
with photodiode array detection. For anaerobic rap-
id reaction experiments, 0.1 WM catalase, 10 mM
glucose, and 10 units ml31 glucose oxidase were
added to the reaction mixtures. The enzyme concen-
tration of nNOS reductase domain was measured at
457 nm using an extinction coe⁄cient of 22.9 mM31
cm31 [31]. The enzyme concentrations of NADPH-
cytochrome P450 reductase was measured at 455nm
(O= 21.4 mM31 cm31) [8], and of NADPH:Q oxido-
reductase at 452nm (O= 11.3 mM31 cm31) [35]. The
rates of NADPH oxidation by MD and Adr were
monitored at 340 nm using an extinction coe⁄cient
of 6.22 mM31 cm31. The rate of NADPH oxidation
by Mit C was monitored at 320 nm using an extinc-
tion coe⁄cient of 4.5 mM31 cm31. For the kinetics
studies, the concentrations of Qs were varied between
1.0 and 400 WM and 100 WM NADPH. Apparent Km
and kcat values were determined from a Line^Weav-
er^Burk plot of the data. The rate of cytochrome c
reduction was measured at 550 nm using an extinc-
tion coe⁄cient of 21 mM31 cm31 [36]. The rate of
cytochrome b5 reduction was measured at 556 nm
using an extinction coe⁄cient of 19.3 mM31 cm31
[37]. The concentrations of Mit C were determined
at 367 nm (O= 21.8 mM31 cm31) [38] and Adr at 480
nm (O= 12.4 mM31 cm31) [39].
The reactivities of air-stable semiquinone with MD
and ferricyanide were measured at 590 nm (O= 2.4
mM31 cm31) [31] for nNOS reductase domain, and
585 nm (O= 2.3 mM31 cm31) [29] for P450 reductase.
The air-stable semiquinone forms of the nNOS re-
ductase domain and P450 reductase were prepared
by the addition of three times excess NADPH in
the presence of air and were allowed to stand for
about 20 min, respectively. Five WM air-stable semi-
quinone was mixed with 40 WM MD in the absence
or presence of 200 WM Ca2, 20 WM CaM, and 25
mM Tris-bu¡er, pH 7.6.
3. Results
3.1. Absorption spectra of the nNOS reductase
domain and P450 reductase
In this study, we compared the absorption spectra
of the nNOS reductase domain and P450 reductase.
The puri¢ed recombinant nNOS reductase domain
and P450 reductase contained approximately equi-
Fig. 1. Absorption spectra of nNOS reductase domain and P450 reductase. The nNOS reductase domain (A) and P450 reductase (B).
Air-stable semiquinones of both enzymes were prepared by adding NADPH (105 WM, ¢nal concentration) in the presence of air to en-
zyme (35 WM) in 10 mM potassium phosphate bu¡er, pH 7.0, containing 5% glycerol. The systems were allowed to stand for about
20 min. (Curve a) oxidized; (curve b) air-stable semiquinone form; (curve c) after addition NADPH (81 WM, ¢nal concentration)
under anaerobic conditions (NADPH-reduced residual semiquinone); (curve d) hydrosul¢te reduced.
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molar quantities of FAD and FMN, respectively.
The visible absorption spectra of the puri¢ed nNOS
reductase domain and P450 reductase at several ox-
idation levels are shown in Fig. 1A,B, respectively.
The oxidized enzyme of the nNOS reductase domain
had absorption peaks at 387 and 457 nm with a
shoulder at 479 nm, but the P450 reductase had no
pronounced shoulder in this region. The air-stable
semiquinone of both enzymes was obtained by the
reduction with NADPH in the presence of air. The
spectrum so obtained (Fig. 1A, curve b) was very
similar to that of the air-stable semiquinone (FAD-
FMNH) of the P450 reductase (Fig. 1B, curve b).
The air-stable semiquinone in both enzymes was not
completely reduced by excess NADPH (Fig. 1A,B,
curves c). On the basis of NADPH-reduced residual
semiquinone of the P450 reductase [8^10], this spec-
trum (Fig. 1A, curve c) corresponds mainly to a
mixture of three-electron and four-electron reduced
forms of P450 reductase [31]. In the NADPH-re-
duced residual semiquinone, a shoulder at 635 nm
of the air-stable semiquinone was not seen in the
P450 reductase (Fig. 1B, curve c), but it was still
retained in the nNOS reductase domain (Fig. 1A,
curve c). In both the presence and absence of Ca2/
CaM, the spectra of curves b and c did not change
(data not shown). These data suggest that the redox
potentials of the two £avins are not modulated by
the binding of CaM.
3.2. The nNOS reductase domain can catalyze
one-electron reduction of Qs
NADPH oxidation by the P450 reductase, which is
a ‘one-electron transfer’ enzyme, is greatly stimulated
by the addition of MD as reported by Iyanagi and
Yamazaki [1,2]. Fig. 2A demonstrates the NADPH
oxidation by the nNOS reductase domain in the
presence of Ca2/CaM and MD. The level of
NADPH-oxidase activity was very low in the absence
of MD, even in the presence of Ca2/CaM, but MD-
mediated NADPH oxidation was increased approx-
imately 12 times by the addition of Ca2/CaM (Fig.
2B). This activation was inhibited by the addition of
excess synthetic CaM peptide, amino acid residues
726^746, RRAIGFKKLAEAVKFSAKLM, (0.5
mM) or EGTA (0.5 mM) (data not shown). When
QR, which is a ‘two-electron transfer’ enzyme was
added during the reaction, the rates for NADPH
oxidation in both the absence and presence of
Ca2/CaM were signi¢cantly decreased (Fig. 2B,C).
P450 reductase catalyzes a one-electron reduction
of both Mit C and Adr, which are antitumor drugs
containing the Q structure, whereas QR catalyzes a
two-electron reduction of these Qs [4,5]. In this work,
we tested whether the nNOS reductase domain cata-
lyzes a one- or two-electron reduction of these anti-
tumor Qs. As shown in Fig. 3A, aerobic NADPH-
oxidation was observed with the addition of Adr and
was stimulated in the presence of Ca2/CaM. A
change in absorbance at 480 nm, which indicates
the absorption peak of oxidized Adr, was not ob-
served during the reaction (Fig. 3A,B), suggesting
that Adr is in the oxidized form without accumula-
tion of the fully reduced form. If the rate of autox-
idation of the fully reduced form, which is formed by
a two-electron reduction, is rate-limiting in the over-
all NADPH-oxidation, Adr would accumulate in the
fully reduced form in the presence of high concen-
trations of the nNOS reductase domain. However,
such a product was not observed even in the presence
of a 10-times excess of the enzyme concentration, as
indicated in Fig. 3A (data not shown). These obser-
vations indicate that Adr was reduced by a one-elec-
tron transfer. Similar results were obtained in the
Fig. 2. MD-mediated aerobic oxidation of NADPH in the
nNOS reductase domain. Concentrations: 0.25 WM nNOS re-
ductase domain (E), 2.4 nM QR, 100 WM NADPH, 10 WM
MD, 200 WM Ca2, 3 WM CaM, and 10 mM Tris bu¡er, pH
7.6. In this system, QR completely reduced MD to the hydro-
quinone form within the mixing time (approximately 2 s). The
rates of NADPH-oxidation were monitored in the presence or
absence of QR (A, B and C), respectively. Additions are indi-
cated by arrows.
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reaction of Mit C (data not shown). The present data
also indicate that the nNOS reductase domain cata-
lyzes a one-electron reduction of antitumor Qs, Adr
and Mit C, as well as simple Q MD. The kinetic
parameters are summarized in Table 1.
We next used cytochrome b5 as a scavenger for the
menasemiquinone radical: anionic semiquinone of
MD (MD3) [1,2,40]. Cytochrome b5 was not re-
duced directly by the nNOS reductase domain, but
it was e¡ectively reduced in the presence of MD (Fig.
4A). The stoichiometry of NADPH-oxidation by
MD versus cytochrome b5 reduction (as determined
from 3d[NADPH]/dt versus d[cytochrome b52]/dt)
corresponded to 0.5 (0.5 þ 0.1, n = 5), as shown in
Fig. 4A. This ratio indicates that 1 mol of NADPH
can reduce 2 mol of cytochrome b5, and that MD
mediates transfer of electrons from NADPH to cy-
tochrome b5 as a one-electron carrier [1,2,40]. On the
other hand, QR did not e¡ectively stimulate the re-
duction of cytochrome b5 in the presence of MD,
although the rate of MD reduction was the same
between the nNOS reductase domain and QR, as
shown in Fig. 4A,B. These results also con¢rm that
the nNOS reductase domain can catalyze only a one-
electron reduction of MD, and the resulting semiqui-
none radical which has the rate constant of 3U108
M31 s31 for cytochrome b5 reduction [40], can rap-
idly react with cytochrome b5 [1].
3.3. Reactivity of the air-stable semiquinone with MD
and ferricyanide.
The air-stable semiquinone of the nNOS reductase
domain is more reduced by one equivalent than is the
fully oxidized enzyme, and its reactivity with cyto-
chrome c is very slow [31]. In this study, we meas-
ured the reactivities of the air-stable semiquinone
with MD and ferricyanide. The air-stable semiqui-
none of the nNOS reductase domain did not react
signi¢cantly with MD. The second order rate con-
stant (as determined from 3d[air-stable semiquinone
form]/dt in the absence of Ca2/CAM) was 3.3U10
M31 s31, but its rate constant was 2.8U102 M31 s31
in the presence of Ca2/CaM.
The data indicate that the activity of the air-stable
semiquinone with MD was increased nine times by
the addition of Ca2/CaM, but these values can not
explain the overall turnover shown in Table 1. A
similar rate constant, 10.5U102 M31 s31, was ob-
tained in the reaction of MD with the air-stable semi-
quinone of P450 reductase.
The second order rate constant of the air-stable
semiquinone with ferricyanide was 1.1U102 M31
s31 in the absence of Ca2/CaM, but its rate constant
was 1.3U103 M31 s31 in the presence of Ca2/CaM.
The data also indicate that the activity of the air-
stable semiquinone with ferricyanide was increased
12 times by the addition of Ca2/CaM.
Table 1
Kinetic parametersa for quinone-induced NADPH oxidation by
the nNOS reductase domain
Ca/CaM MQ Adr Mit C
kcat (min31) 3 126 þ 9 136 þ 26 55 þ 11
+ 2368 þ 144 1664 þ 260 1016 þ 120
Km (WM) 3 11.2 þ 1.5 13.6 þ 4.4 113.8 þ 37.0
+ 24.6 þ 2.3 12.6 þ 3.4 206.8 þ 30.4
aKinetic parameters were determined by monitoring NADPH
oxidation in three independent experiments, as described in the
text
Fig. 3. Adr-mediated aerobic NADPH-oxidation (A), change of
absorption with time at 480 nm (B) and its absorption spectra
(C) observed during the nNOS reductase reaction. Concentra-
tions: (A) 0.25 WM nNOS reductase domain, 100 WM NADPH,
200 WM Ca2, 3 WM CaM, 13 WM Adr, 10 mM Tris bu¡er, pH
7.6. (B) The oxidation-reduction state of Adr was monitored at
480 nm in the same conditions as A. (C) (curve a) the spectra
of the mixture containing Adr, NADPH and Ca2/CaM; (curve
b) 20 min after the start of the reaction by addition of nNOS
reductase domain; (curve c) curve b was reduced by the addi-
tion of hydrosul¢te. Additions are indicated by arrows.
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3.4. Flavin intermediates observed during oxidation of
the reduced enzyme by MD
We studied the role of an FAD-FMN pair in one-
electron reduction of MD. On the basis of similar
redox properties with P450 reductase (Fig. 1A,B,
and [15,31]), the absorbance changes at 457 nm
(the sum of the formation of semiquinone and re-
duced forms), 504 nm (the formation of the fully
reduced species), and 590 nm (the formation of
both fully reduced and semiquinone £avin species)
were monitored (Fig. 5). The oxidized P450 reductase
(FAD-FMN) was mixed with NADPH plus MD so-
lution. The results are shown in Fig. 5A. The de-
crease in the absorbance at 455 nm parallels the in-
crease at 585 nm, but the absorbance change at 503
nm, which would decrease on the formation of a
fully reduced £avin species, is relatively constant.
When the air-stable semiquinone (FAD-FMNH)
was mixed with NADPH plus MD, a signi¢cant
change at all three wavelengths was not observed
(Fig. 5A). These data con¢rm the previous evidence
that the air-stable semiquinone is a predominant in-
termediate observed during the oxidation of the re-
duced enzyme by MD [29]. In the presence of Ca2/
CaM, the oxidized nNOS reductase domain (FAD-
FMN) was mixed with NADPH plus MD solution.
The results are shown in Fig. 5B. The decrease in the
absorbance at 457 nm parallels the increase at 590
nm, but the absorbance change at 504 nm was rela-
tively constant. These results indicate that the fully
Fig. 5. Changes of absorption with time at three wavelengths
during reaction of MD and the nNOS reductase domain with
NADPH followed in a stopped-£ow apparatus. Oxidized (left
panel) or air-stable semiquinone (right panel) of P450 reductase
and the nNOS reductase domain were mixed anaerobically with
NADPH plus MD and the absorbance changes were recorded
at three wavelengths. (A) The oxidized or air-stable semiqui-
none of P450 reductase. (B) The oxidized or air-stable semiqui-
none of nNOS reductase domain in the presence of Ca2/CaM.
(C) The oxidized or air-stable semiquinone of nNOS reductase
domain in the absence of Ca2/CaM. Final concentrations after
mixing: 5 WM oxidized enzyme or air-stable semiquinone, 20
WM NADPH, 40 WM MD, and 25 mM HEPES bu¡er, pH 7.0.
Before mixing, 10 WM nNOS reductase domain solutions were
incubated for 20 min with 400 WM Ca2, and 20 WM CaM. In
the P450 reductase system, CaM was removed from the enzyme
solutions.
Fig. 4. MD-mediated reduction of cytochrome b5 in the nNOS
reductase domain (A) and QR (B) systems. (A) The solution of
the nNOS reductase domain containing Ca/CaM was mixed
with the solution of cytochrome b5, NADPH, and MQ, anae-
robically. (B) The solution of QR was mixed with solution of
cytochrome b5, NADPH, and MQ, anaerobically. Final concen-
trations after mixing: 0.25 WM nNOS reductase domain, 100
WM NADPH, 7 WM cytochrome b5, 20 WM MQ, 200 WM
Ca2, 3 WM CaM, 0.75 nM QR, 10 mM potassium phosphate
bu¡er, pH 7.0. NADPH-oxidation was measured in the absence
of cytochrome b5 in both systems (A and B).
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reduced species of the two £avins do not accumulate
measurably during the oxidation of the reduced en-
zyme by MD. When the air-stable semiquinone form
was mixed with NADPH plus MD (Fig. 5B), changes
in the absorbance at 457 and 590 nm were observed.
The increase of absorbance at 590 nm strongly sug-
gests the formation of another semiquinone species,
probably a semiquinone radical derived from the
FAD moiety (Fig. 5B), but such an absorbance
change was not observed in the P450 reductase
(Fig. 5A). Its concentration was approximately 30%
of the air-stable semiquinone. When the oxidized
nNOS reductase domain (FAD-FMN) was mixed
with NADPH plus MD in the absence of Ca2/
CaM, absorbances at 457 nm and 590 nm were in-
creased more than those in the presence of Ca2/
CaM (Fig. 5C). The increase of absorbance at 590
nm occurred without a lag phase, and its rate was
more rapid than that in the presence of Ca2/CaM.
Furthermore, when the air-stable semiquinone was
mixed with NADPH plus MD, similar results to
that of Fig. 5B were observed (Fig. 5C). In both
the presence and absence of Ca2/CaM, the semiqui-
none species accumulated after the reaction, as
shown in Fig. 5B,C. The spectra were monitored
by rapid-scan spectrophotometry (Fig. 6). These
data strongly suggest that the air-stable semiquinone
form is the predominant intermediate observed dur-
ing the oxidation of the enzyme reduced by MD, but
another semiquinone species is also observed during
the reaction. These semiquinone species do not react
signi¢cantly with MD.
3.5. Flavin intermediates observed during oxidation of
the reduced enzyme by ferricyanide
The reduction rate of ferricyanide was approxi-
mately doubled in the presence of Ca2/CaM [31].
In this study, we directly observed the reactivity of
the reduced enzyme with ferricyanide. The oxidized
nNOS reductase domain (FAD-FMN) was mixed
with NADPH in the presence of excess ferricyanide.
The results are shown in Fig. 7A,B. In the presence
Fig. 7. Changes of absorption with time at three wavelengths
during the reaction of ferricyanide and the nNOS reductase do-
main with NADPH followed in a stopped-£ow apparatus. Oxi-
dized enzyme of the nNOS reductase domain was anaerobically
mixed with NADPH plus ferricyanide and the absorbance
changes were recorded at three wavelengths. The oxidized en-
zyme of nNOS reductase domain absent (A) or present (B). Fi-
nal concentrations after mixing: 8.7 WM oxidized enzyme 21.6
WM NADPH, 500 WM ferricyanide, and 25 mM HEPES bu¡er,
pH 7.0. Before mixing, the nNOS reductase domain solutions,
17.7 WM were incubated for 20 min with 400 WM Ca2, and 21
WM CaM.
Fig. 6. Spectral changes of the oxidized enzyme followed by a
rapid scan spectrophotometer after mixing with NADPH plus
MD. The oxidized enzyme was mixed anaerobically with
NADPH plus MD and each spectrum was recorded at 15, 37,
57, 117, and 237 ms (a^e, respectively). Final concentrations
after mixing: 8 WM nNOS reductase domain, 500 WM Ca2, 20
WM NADPH, 40 WM MD and 25 mM HEPES bu¡er, pH 7.0.
The spectra are recorded from 410 to 520 and 520 to 700 nm,
respectively.
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of Ca2/CaM, the decrease in the absorbance at 457
nm parallels the increase at 590 nm, and its rate at
590 nm was approximately twice as high as that in
the absence of Ca2/CaM (Fig. 7A,B).
4. Discussion
Reduced £avin can be oxidized sequentially via
two one-electron processes involving the semiqui-
none radical [41]. In 1971, Yamazaki suggested a
tentative de¢nition of one-electron and two-electron
transfer mechanisms [42]. For the electron transfer
between reduced £avin enzyme (E-FlH2) and Q the
following Scheme 1 can be drawn. In some cases the
reverse reaction also takes place. When the reaction
proceeds along route a, it is termed a two-electron
mechanism regardless of the lifetime of the one-elec-
tron transfer intermediate (E-FlH^QH). The hy-
dride transfer also belongs to this category. A one-
electron transfer mechanism then implies that the
intermediate (E-FlH^QH) releases only semiqui-
none radicals (QH) via a reaction path indicated
by route b. The semiquinone radical (QH) thus
formed will transfer one electron between the same
semiquinone radical species, and the ¢nal product is
QH2. The semiquinone radical intermediate formed
in route b is detected with the aid of the electron
paramagnetic resonance (EPR) technique [1,2].
When the steady state concentration of a semiqui-
none radical is below the level of EPR sensitivity,
semiquinone radical scavengers, including molecular
oxygen and cytochromes, can be used for detection
of the semiquinone radical [1,2]. On the basis of this
background, we studied the mechanism of Q reduc-
tion by the nNOS reductase domain (FAD-FMN).
As shown in Figs. 2^4, the present data clearly dem-
onstrate that the nNOS reductase domain catalyzes a
typical one-electron reduction of Qs, such as MD
(3210 mV) [28], Mit C (3271 mV) [39] and Adr
(3292 mV) [39] (Fig. 8). Therefore, the reduction
of these Qs proceeds along route b. The one-electron
reduction potential of various Qs is related to their
reduction rates by the nNOS reductase domain1. On
the other hand, QR can catalyze the two electron
reduction of MD (Figs. 2 and 4, and [2]), but QR
did not signi¢cantly reduce Adr and Mit C (data not
shown).
The nNOS reductase domain has redox properties
similar to those of P450 reductase (FAD-FMN) [31].
Iyanagi, Makino and Mason measured one-electron
redox potentials of FAD and FMN of the P450 re-
Fig. 8. One-electron oxidation-reduction potentials of microso-
mal P450 reductase, the nNOS reductase domain, and various
Qs. The redox potentials of the £avins of P450 reductase
(FAD-FMN) and the nNOS reductase domain (FAD-FMN)
are given as reported in [9] and [45], respectively. MD (3210
mV) [28], Mit C (3271 mV) [39], and Adr (3292) [39]. It is
possible that NADP or NADPH binding to the nNOS reduc-
tase domain stabilized the FAD semiquinone by shifting the re-
duction potential to a more negative value [45].
Scheme 1. The mechanism of electron transfer in the overall bivalent oxidation-reduction reaction. E-FlH2 indicates enzyme-bound re-
duced £avin, and E-FlH^QH corresponds to a primarily formed one-electron transfer intermediate [3].
1 Kitamura, M and Iyanagi, T, unpublished data.
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ductase [9], and assigned values to the redox couples
at 3110, 3270, 3290 and 3365 mV, which represent
the couples FMN/FMNH, FMNH/FMNH2, FAD/
FADH, and FADH/FADH2, respectively [43,44]
(Fig. 8). Recently, Nobel et al. reported one-electron
redox potentials of FAD and FMN of the nNOS
reductase domain (amino acid residues 695^1429)
and determined values for the redox couples at
349, 3274, 3232, and 3280 mV, which represent
the couples FMN/FMNH, FMNH/FMNH2,
FAD/FADH, and FADH/FADH2, respectively
[45] (Fig. 8). The redox couple FMNH/
FMNH2 =3274 mV of nNOS reductase is very sim-
ilar with that of P450 reductase (Fig. 8), and its value
is una¡ected by the binding of CaM [45]. The FMN-
depleted enzyme of the P450 reductase (FAD) is un-
able to catalyze either reduction of MD (3210 mV)
and cytochrome c (+250 mV), although these reac-
tions are thermodynamically favored. This enzyme
can catalyze the reduction of ferricyanide, but its
reactivity with the FAD semiquinone is slower than
that of the fully reduced FAD [29]. The air-stable
semiquinone FAD-FMNH does not react signi¢-
cantly with MD (see Section 3). These data indicate
that the redox couple FMNH/FMNH2 =3270 mV
of P450 reductase can reduce directly various Qs
with low one-electron redox potentials [3^5,28]
(Fig. 8). The air-stable semiquinone of the nNOS
reductase domain has similar oxidation levels to
that of P450 reductase [15,31,45,46], and it also
does not react signi¢cantly with MD (see Section
3). This state is rapidly reduced by NADPH in the
three-electron reduced species (Fig. 1, and [31]).
These data suggest that the redox couple FMNH/
FMNH2 =3274 mV of the nNOS reductase domain
also can donate an electron to various Qs (Fig. 8). In
the presence of Ca2/CaM, the air-stable semiqui-
none, FAD-FMNH is the predominant intermediate
observed during oxidation of the reduced nNOS re-
ductase domain by MD (Fig. 5B). In addition to this
intermediate, other semiquinone species, probably
FADH-FMNH and FADH-FMN, could be
formed during the oxidation of the reduced enzyme
by MD, as shown in Fig. 5B,C. Such an absorbance
change was not observed in P450 reductase (Fig.
5A). This di¡erence suggests that the fully reduced
FAD of the nNOS reductase domain can react di-
rectly with MD, and the resulting semiquinone spe-
cies of FAD has low reactivity toward MD. In fact,
the formation of semiquinone, inferred from the in-
crease of absorbance at 590 nm, occurred with a lag
phase in the absence of Ca2/CaM [31], but its for-
mation occurred without a lag phase when MD is
added to the reaction mixture (Fig. 5C). This obser-
vation was directly con¢rmed by rapid-scan spectro-
photometry (Fig. 6). These data strongly support the
idea that the semiquinones (FADH-FMN or
FADH-FMNH) derived from FAD could be
formed during the oxidation of the reduced enzyme
by MD. When ferricyanide, which can react directly
with FAD [31], was used as a one-electron acceptor,
similar results to those of Fig. 5B,C were observed
(Fig. 7A,B). The fully reduced £avin species, as
judged by the absorbance change at 504 nm, did
not signi¢cantly accumulate during the oxidation of
the reduced enzyme by MD under these conditions
(Fig. 5B,C). These accumulated data indicate that
both the fully reduced £avins, FADH2 and FMNH2,
can donate electrons to MD molecules, but their
semiquinone states do not react rapidly with MD.
The two-electron reduced enzyme (FADH-
FMNH3FAD-FMNH2) can donate electrons to
MD. Therefore, the FAD-FMN pair shuttles be-
tween the one-electron (FADH-FMN3FAD-
FMNH) and three-electron (FADH2-FMNH3
FADH-FMNH2) reduced states, and the redox
couple, FMNH/FMNH2 is the most reactive £a-
vin species with MD at the catalytic cycle. In the
presence of Ca2/CaM, the rate of Q reduction is
stimulated by a rapid electron exchange between
the two £avins during catalytic turnover. Further
analysis of the kinetic modeling to justify the mech-
anisms of these complex reactions remains to be
done.
In conclusion, we demonstrated that the nNOS
reductase domain does catalyze the one-electron re-
duction of Qs with fairly low one-electron redox po-
tentials (Fig. 8). The role of each £avin of the nNOS
reductase domain has been proposed based on sim-
ilarities with that of the P450 reductase
[9,21,29,31,44^47] and the X-ray crystal structure of
P450 reductase [48,49]: FAD accepts the two-elec-
tron transfer from NADPH as a hydride ion, while
the FMNH2 is the most reactive species with Qs. The
enzyme catalyzes only a one-electron reduction of Qs
during the 1e333e3 catalytic cycle, and the rate of
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Q reduction is stimulated by a rapid electron ex-
change between the two £avins in the presence of
Ca2/CaM.
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